Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC
Filed with the SEC on · accession 0000886982-26-000564
SION filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 9, 2026. Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of 2,639,418 shares, or 5.8%, of Sionna Therapeutics common stock as of September 30, 2026. The stock moved +8.8% by the first close after the filing.
Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of 2,639,418 shares, or 5.8%, of Sionna Therapeutics common stock as of September 30, 2026. The filing is a passive institutional ownership disclosure.
Close before
$3.28
Nov 6, 2026
First close after
+8.84%
$3.57
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SION, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SION?
Click hereSION filed a SCHEDULE 13G (SEC filing). Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC filed a Schedule 13G reporting beneficial ownership of 2,639,418 shares, or 5.8%, of Sionna Therapeutics common stock as of September 30, 2026. The filing is a passive institutional ownership disclosure.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
SION closed at $3.28 before the filing and $3.57 on Nov 9, 2026 (+8.84%).
Get alerts when SION files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days